Avacta Group Plc (OTCMKTS:AVCTF – Get Free Report)’s share price dropped 6.9% on Wednesday . The stock traded as low as $0.7434 and last traded at $0.7434. Approximately 3,750 shares were traded during trading, a decline of 84% from the average daily volume of 22,783 shares. The stock had previously closed at $0.7981.
Avacta Group Stock Performance
The stock has a 50-day moving average price of $0.93 and a 200-day moving average price of $0.83.
About Avacta Group
Avacta Group plc is a UK-based biotechnology company specializing in the discovery, development and commercialization of Affimer® biotherapeutics and diagnostic reagents. The company’s proprietary Affimer platform uses small, engineered protein scaffolds that can be tailored to bind specifically to target molecules, offering an alternative to traditional antibodies. Avacta operates two core divisions: Avacta Therapeutics, which focuses on novel treatments in oncology and immune-related diseases, and Avacta Analytical, which develops reagents and point-of-care diagnostic tests.
In its diagnostics business, Avacta has applied the Affimer technology to lateral flow assays, most notably for rapid detection of viral pathogens such as SARS-CoV-2.
Further Reading
- Five stocks we like better than Avacta Group
- A month before the crash
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Wall Street Alert: Buy AES
- Bitcoin is down but your income is about to explode
- Trump Devises the Death of the IRS ☠️
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.
